Balancing nanotoxicity and returns in health applications: The Prisoner’s Dilemma

Advancing intestinal organoid technology to decipher nano-intestine interactions and treat intestinal disease

With research burgeoning in nanoscience and nanotechnology, there is an urgent need to develop new biological models that can simulate native structure, function, and genetic properties of tissues to evaluate the adverse or beneficial effects of nanomaterials on a host. Among the current biological models, three-dimensional (3D) organoids have developed as powerful tools in the study of nanomaterial-biology (nano-bio) interactions, since these models can overcome many of the limitations of cell and animal models. A deep understanding of organoid techniques will facilitate the development of more efficient nanomedicines and further the fields of tissue engineering and personalized medicine. Herein, we summarize the recent progress in intestinal organoids culture systems with a focus on our understanding of the nature and influencing factors of intestinal organoid growth. We also discuss biomimetic extracellular matrices (ECMs) coupled with nanotechnology. In particular, we analyze the application prospects for intestinal organoids in investigating nano-intestine interactions. By integrating nanotechnology and organoid technology, this recently developed model will fill the gaps left due to the deficiencies of traditional cell and animal models, thus accelerating both our understanding of intestine-related nanotoxicity and the development of nanomedicines.

A key moment for TiO2: Prenatal exposure to TiO2 nanoparticles may inhibit the development of offspring

Applications of TiO₂ nanoparticles (NPs) in food, personal care products and industries pose risks on human health, particularly on vulnerable populations including pregnant women and infants. Fetus, deficient in mature defense system, is more susceptible to NPs. Publications on the developmental toxicity of TiO₂ NPs on the maternal-exposed progeny have emerged. This review presents the main exposure routes of TiO₂ NPs during pregnancy, including skin penetration, ingestion and inhalation, followed by transport of TiO₂ NPs to the placenta. Accumulation of TiO₂ NPs in placenta may cause dysfunction in nutrient transfer. TiO₂ NPs can be even transported to the fetus and generate toxicities, such as impairments of nervous and reproductive system, and failure in lung and cardiovascular development. The toxicities rely on the crystalline phase and concentrations, and the main mechanisms include the accumulation of excessive reactive oxygen species, DNA damage, and over-activation of signaling pathways such as MAPK which impairs neurotransmission. Finally, this review remarks on the significance for identifying TiO₂ NPs dosage safe for both mother and fetus, and particular attention should be paid at TiO₂ NPs concentrations safe for mother but toxic to fetus. Importantly, research on the epigenetic trans-generational inheritance of TiO₂ NPs is urgently needed to provide insights for deciding the prospects of TiO₂ NPs applications.

Carbon family nanomaterials — new applications and technologies

Research on carbon-based nanomaterials (CBNMs) and their development is one of the major scientific disciplines of the last century. This is mainly because of their unique properties which can lead to improvements in industrial technology or new medical applications. Therefore, it is necessary to examine their properties such as shape, size, chemical composition, density, toxicity, etc. This article focuses on the general characteristics of nanomaterials (NMs) and their behavior when entering the environment (water and soil). In addition, it presents individual members of the graphene family including porous ecological carbon (biochar). The article mainly deals with the new potential technologies of CBNMs considering their possible toxic and genotoxic effects. This review also highlights the latest developments in the application of self-propelled micromotors for green chemistry applications. Finally, it points to the potential biomedical applications of CBNMs.

In vitro and in vivo toxicological evaluation of transition metal-doped titanium dioxide nanoparticles: Nickel and platinum

Transition metal-doped titanium dioxide nanoparticles (M-TiO₂ NPs) have been studied to enhance the activity of TiO₂ NPs in biomedical applications. In this study, in vitro and in vivo toxicological aspects of M-TiO₂ NPs were reported to assess the safety of these materials. M-TiO₂ NPs were synthesized via a photo-deposition technique. Nickel (Ni) and platinum (Pt) were used as dopants. Physicochemical properties, cytotoxicity, phototoxicity, gene ontology (GO) and dermal toxicity of M-TiO₂ NPs were investigated. Ni-TiO₂ (Ni, 1.02%) and Pt-TiO₂ (Pt, 0.26%) NPs were sphere shape crystals with nanoscale size. ARPE-19 cells were more susceptible to Pt-TiO₂ NPs (EC50, 0.796 mg/mL) than Ni-TiO₂ NPs (EC50, 2.945 mg/mL). M-TiO₂ NPs were rated as probably phototoxic to phototoxic. GO suggested binding function and metabolic processes as a risk mechanism of M-TiO₂ NPs. In vivo toxicological effects of Ni-TiO₂ NPs were not observed on body weight, serum aspartate transaminase/alanine transaminase levels, and skin histology at 61.5-6150 mg/kg. Specifically, skin thickness was not significantly modified (max. 33.2 ± 8.7 μm) and inflammation grade was less than level 2 (max. 1.2 ± 0.4). From these results, Ni-TiO₂ and Pt-TiO₂ NPs show promise as enhanced photocatalysts for safe and sustainable usage.

Cardiopulmonary consequences of gestational toxicant exposure: Symposium overview at the 56th annual SOT meeting, Baltimore, MD

Xenobiotic exposures affect the maternal and/or in utero environment resulting in impairments in fetal development. During the period of rapid fetal growth, developing cardiovascular systems are especially vulnerable to their environment. Furthermore, fetal exposures can evoke changes in epigenetic signatures that result in permanent modifications in gene expression. This symposium focused on the intersection between maternal and fetal exposure and the developing cardiovascular system. The impact of maternal exposures on prenatal development is of major concern for regulatory agencies given the unique vulnerability of the embryo/fetus to environmental factors, the importance of vascular biology to maternal-fetal interactions, and the adverse consequences of vascular disruption to children's health. Speakers provided data from diverse exposures: nanomaterials, particulate matter or air pollution (PM_2.5), nicotine, and environmental chemicals. The current findings related to susceptible gestational windows for cardiovascular development and epigenetic, transcriptomic, toxicokinetic, and toxicodynamic changes in vascular physiology and cardiac function. In response to these concerns, new concepts in predictive modeling and risk assessment associated with in utero exposures were presented as future avenues of research within developmental toxicology. Finally, current applications using an Adverse Outcome Pathway framework for developmental toxicity were presented to integrate data from in vitro profiling of chemical libraries (e.g. ToxCast™) with computational models for in silico toxicology. In summary, this symposium addressed the significant threats to cardiovascular health that are associated with fetal/perinatal exposures, and offered new insights into the predictive, mechanistic, and risk assessment strategies in developmental toxicology.